Mercato chiuso -
Altri mercati azionari
|
Variaz. 5gg | Var. 1 gen. | ||
215 INR | -3,63% | -7,45% | +25,88% |
Attività
Numero di dipendenti: 1 295
Vendite per attività
INR in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Contract Research and Manufacturing Services
80,6
%
| 16 493 | 77,0 % | 19 453 | 80,6 % | +17,95% |
Marketable Molecules (including Others)
19,4
%
| 4 914 | 23,0 % | 4 676 | 19,4 % | -4,83% |
Vendite per regione
INR in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
India
100,0
%
| 367 | 1,7 % | 24 129 | 100,0 % | +6.483,68% |
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Chief Executive Officer | 38 | 07/04/12 | |
Harshil R. Dalal
DFI | Director of Finance/CFO | 42 | - |
Paolo Armanino
COO | Chief Operating Officer | - | - |
Compliance Officer | 37 | 17/03/17 | |
Dharmesh Desai
LAW | General Counsel | - | - |
Martin Schneider
PRN | Corporate Officer/Principal | - | - |
Stephan Fritschi
PRN | Corporate Officer/Principal | 63 | - |
Dieter Thueer
HRO | Human Resources Officer | - | - |
Alan Fischer
PRN | Corporate Officer/Principal | - | - |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Chairman | 73 | 17/03/07 | |
Director/Board Member | 73 | 17/03/17 | |
Director/Board Member | 76 | 17/03/17 | |
Chief Executive Officer | 38 | 07/04/12 | |
Subir Kumar Das
BRD | Director/Board Member | 70 | 17/03/17 |
Director/Board Member | 42 | 01/04/19 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 156 783 095 | 46 925 444 ( 29,93 %) | 0 | 29,93 % |
Coordinate società
Dishman Carbogen Amcis Ltd.
Dishman Corporate House Opp. Jayantilal Park BRTS
380058, Ahmedabad
+91 27 1742 0102
http://imdcal.comSocietà del gruppo
Nome | Categoria e settore |
---|---|
Dishman Europe Ltd.
Dishman Europe Ltd. Pharmaceuticals: MajorHealth Technology Part of Adimans Technologies LLP, Dishman Europe Ltd. is a British company that imports and markets a wide range of chemical products and pharmaceutical ingredients. The private company is based in London, UK. Dishman Europe was founded in 1997. |
Pharmaceuticals: Major
|
Dishman Netherlands BV
Dishman Netherlands BV Pharmaceuticals: OtherHealth Technology Part of Adimans Technologies LLP, Dishman Netherlands BV is a Dutch innovative company dedicated to the re-use of critical raw materials. The private company successfully developed a market study for the EU funded REECOVER project, focused on the re-use of rare earths from electronic waste and mine tailings. Currently, in the EU funded ICARUS project, Dishman Netherlands is responsible for market studies, IPR management, and the exploitation process of the technologies that are being developed to recycle silicon kerf, graphite, and silica. The company's current trade business activities consist of the trade in triphenyl phosphine oxide (Tppo), which has been one of the company's activities for more than 20 years, with large multinational companies as its main clients. |
Pharmaceuticals: Other
|
Settore
Vendite per attività
Vendite per regione
Fatturato trimestrale - Indice di sorpresa
Variaz. 1 gen. | Capi. | |
---|---|---|
+32,76% | 690 Mrd | |
+26,43% | 546 Mrd | |
-4,95% | 358 Mrd | |
+17,99% | 323 Mrd | |
+4,98% | 287 Mrd | |
+14,36% | 235 Mrd | |
+5,77% | 199 Mrd | |
-9,41% | 195 Mrd | |
+4,82% | 161 Mrd |
- Borsa valori
- Azioni
- Azione DCAL
- Azione DCAL
- Società Dishman Carbogen Amcis Limited